Sign in

CIK 0001055726

  • Non-accelerated filer
  • Smaller reporting company

INOVIO PHARMACEUTICALS, INC.

Sign in to watch
Ticker
INO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330969592
Phone
+1 858-410-3134
Business address
660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
Former names
INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
  1. 4 Open-market sale CFO sold 35,000 shares at $26.50 ($927,500)
  2. 4 Open-market sale Chief Scientific Officer sold 19,467 shares at $14.70 ($286,165)
  3. 4 Open-market sale Director sold 8,750 shares at $15.95 ($139,594)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale Director sold 2,404 shares at $11.84 ($28,463)
  11. 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 8,013 shares (option exercise)
  17. 4 Shares withheld for taxes Chief Operating Officer gave up 4,747 shares (to pay taxes)
  18. 4 Exercise or conversion Director acquired 4,274 shares (option exercise)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 36,826 shares (to pay taxes)
  20. 4 Derivatives Options or other derivatives

Page 10 of 30 · 592 filings